Found: 37
Select item for more details and to access through your institution.
Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.
- Published in:
- International Journal of Neuropsychopharmacology, 2005, v. 8, n. 3, p. 427, doi. 10.1017/s1461145705005225
- By:
- Publication type:
- Article
Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone
- Published in:
- European Psychiatry, 2004, v. 19, n. 4, p. 219, doi. 10.1016/j.eurpsy.2003.11.007
- By:
- Publication type:
- Article
ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial.
- Published in:
- Journal of Attention Disorders, 2014, v. 18, n. 2, p. 123, doi. 10.1177/1087054712448252
- By:
- Publication type:
- Article
Clinically Relevant Changes in Emotional Expression in Children With ADHD Treated With Lisdexamfetamine Dimesylate.
- Published in:
- Journal of Attention Disorders, 2012, v. 16, n. 5, p. 384, doi. 10.1177/1087054710389990
- By:
- Publication type:
- Article
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0318-y
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended Release in Adults With Attention-Deficit/Hyperactivity Disorder.
- Published in:
- Primary Psychiatry, 2010, v. 17, n. 9, p. 44
- By:
- Publication type:
- Article
RELATIONSHIP BETWEEN VASCULAR PATHOLOGY AT BASELINE AND AMYLOID-RELATED IMAGING ABNORMALITIES (ARIA) IN PRODROMAL AD PATIENT POPULATION IN SCARLET ROAD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P254, doi. 10.1016/j.jalz.2017.06.115
- By:
- Publication type:
- Article
CORRELATION BETWEEN BASELINE VASCULAR PATHOLOGY/RISK FACTORS AND PROGRESSION OF ALZHEIMER'S DISEASE IN A PRODROMAL POPULATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P255, doi. 10.1016/j.jalz.2017.06.117
- By:
- Publication type:
- Article
THE EFFECT OF 6 MONTHS’ DOSING ON THE RATE OF AMYLOID-RELATED IMAGING ABNORMALITIES (ARIA) IN THE MARGUERITE ROAD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P252, doi. 10.1016/j.jalz.2017.06.112
- By:
- Publication type:
- Article
IDENTIFICATION OF PREDICTORS OF DISEASE PROGRESSION IN AN AMYLOID-BETA 42 (Aβ42)-POSITIVE, PRODROMAL ALZHEIMER’S DISEASE COHORT: ANALYSIS OF THE SCARLET ROAD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P829, doi. 10.1016/j.jalz.2016.06.1689
- By:
- Publication type:
- Article
GANTENERUMAB TREATMENT REDUCES BIOMARKERS OF NEURONAL AND SYNAPTIC DEGENERATION IN ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P198, doi. 10.1016/j.jalz.2016.06.346
- By:
- Publication type:
- Article
THE PREDICTIVE UTILITY OF COGNITIVE MEASURES AT SCREENING FOR DETERMINATION OF CSF ABETA (1-42) STATUS IN SUBJECTS WITH PRODROMAL ALZHEIMER'S DISEASE: DATA FROM THE SCARLET ROAD TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P821, doi. 10.1016/j.jalz.2016.06.1668
- By:
- Publication type:
- Article
FREE AND CUED SELECTIVE REMINDING TEST AS AN INCLUSION CRITERION FOR EARLY ALZHEIMER'S DISEASE CLINICAL TRIAL POPULATIONS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P343, doi. 10.1016/j.jalz.2016.06.635
- By:
- Publication type:
- Article
Efficacy and safety of gantenerumab in prodromal Alzheimer’s disease: Results from scarlet road—a global, multicenter trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P331, doi. 10.1016/j.jalz.2015.08.153
- By:
- Publication type:
- Article
Biomarker data from scarlet road: A global phase 3 study of gantenerumab in patients with prodromal Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P331, doi. 10.1016/j.jalz.2015.08.152
- By:
- Publication type:
- Article
Identifying clinically relevant milestone decline in predementia Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P155, doi. 10.1016/j.jalz.2015.07.085
- By:
- Publication type:
- Article
The effects of lisdexamfetamine dimesylate on emotional lability in children aged 6–12 years with attention-deficit/hyperactivity disorder in a double-blind, placebo-controlled trial.
- Published in:
- European Child & Adolescent Psychiatry, 2010, v. 19, p. S78, doi. 10.1007/s00787-010-0117-5
- By:
- Publication type:
- Article
Consortium for the Lifespan Examination of ADHD Registry (CLEAR) Study: a phase 4 international, longitudinal, observational study of individuals with attention-deficit/hyperactivity disorder (ADHD).
- Published in:
- European Child & Adolescent Psychiatry, 2010, v. 19, p. S24, doi. 10.1007/s00787-010-0117-5
- By:
- Publication type:
- Article
Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval.
- Published in:
- Annals of General Psychiatry, 2007, v. 6, p. 3, doi. 10.1186/1744-859X-6-3
- By:
- Publication type:
- Article
Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 6, p. 1388, doi. 10.1038/npp.2013.334
- By:
- Publication type:
- Article
Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 11, p. 2140, doi. 10.1038/npp.2013.111
- By:
- Publication type:
- Article
Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation.
- Published in:
- 2007
- By:
- Publication type:
- Correction Notice
Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 11, p. 2505, doi. 10.1038/sj.npp.1301113
- By:
- Publication type:
- Article
Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation.
- Published in:
- 2006
- By:
- Publication type:
- Correction Notice
Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated With Lisdexamfetamine Dimesylate.
- Published in:
- Innovations in Clinical Neuroscience, 2012, v. 9, n. 5/6, p. 22
- By:
- Publication type:
- Article
Lisdexamfetamine Dimesylate for the Treatment of Attention Deficit Hyperactivity Disorder in Adults With a History of Depression or History of Substance Use Disorder.
- Published in:
- Innovations in Clinical Neuroscience, 2011, v. 8, n. 2, p. 28
- By:
- Publication type:
- Article
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
- Published in:
- BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-39
- By:
- Publication type:
- Article
Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study.
- Published in:
- Health & Quality of Life Outcomes, 2012, v. 10, n. 1, p. 47, doi. 10.1186/1477-7525-10-47
- By:
- Publication type:
- Article
Diagnosis and Treatment of Geriatric Depression.
- Published in:
- CNS Drugs, 1998, v. 9, n. 1, p. 17, doi. 10.2165/00023210-199809010-00003
- By:
- Publication type:
- Article
A New Psychosocial Tool for Gaining Patient Understanding and Acceptance of Long-acting Injectable Antipsychotic Therapy.
- Published in:
- Psychiatry (1550-5952), 2009, v. 6, n. 4, p. 22
- By:
- Publication type:
- Article
Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use.
- Published in:
- Advances in Therapy, 2013, v. 30, n. 5, p. 472, doi. 10.1007/s12325-013-0027-2
- By:
- Publication type:
- Article
Remisión en la esquizofrenia: criterios y razones para un consenso.
- Published in:
- American Journal of Psychiatry - Edición Española, 2005, v. 8, n. 6, p. 329
- By:
- Publication type:
- Article
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
- Published in:
- International Journal of Geriatric Psychiatry, 2004, v. 19, n. 9, p. 898, doi. 10.1002/gps.1184
- By:
- Publication type:
- Article
APOLIPOPROTEIN E ε4 ALLELE IN ASSOCIATION WITH GLOBAL COGNITIVE PERFORMANCE AND CSF MARKERS IN ALZHEIMER'S DISEASE.
- Published in:
- International Journal of Geriatric Psychiatry, 1998, v. 13, n. 11, p. 767, doi. 10.1002/(SICI)1099-1166(1998110)13:11<767::AID-GPS866>3.0.CO;2-F
- By:
- Publication type:
- Article